Correlation Between Anebulo Pharmaceuticals and Evogene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Evogene, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Evogene.

Diversification Opportunities for Anebulo Pharmaceuticals and Evogene

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Anebulo and Evogene is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Evogene go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Evogene

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.41 times more return on investment than Evogene. However, Anebulo Pharmaceuticals is 1.41 times more volatile than Evogene. It trades about -0.19 of its potential returns per unit of risk. Evogene is currently generating about -0.33 per unit of risk. If you would invest  189.00  in Anebulo Pharmaceuticals on September 4, 2024 and sell it today you would lose (45.00) from holding Anebulo Pharmaceuticals or give up 23.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.24%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  Evogene

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Evogene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Anebulo Pharmaceuticals and Evogene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and Evogene

The main advantage of trading using opposite Anebulo Pharmaceuticals and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.
The idea behind Anebulo Pharmaceuticals and Evogene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Share Portfolio
Track or share privately all of your investments from the convenience of any device